Skip to main content
. 2021 Oct 28;13(11):1803. doi: 10.3390/pharmaceutics13111803

Figure 8.

Figure 8

Schematic illustration showing (a) the DOX- and Mel-loaded NS platform as a DDS and synergistic CTX/PTT treatment of tumors, (b) release profiles of DOX with or without 808 nm laser at various times and pH values, and (c) photographs of the dissected tumors at the end of the treatment of the mice (adapted with permission from Reference [53], Colloids and Surfaces B: Biointerfaces, published by Elsevier, 2020).